STATE STREET CORP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$203,718,000
+46.8%
1,183,716
+7.0%
0.01%
+57.1%
Q2 2021$138,776,000
+2.6%
1,105,870
+10.9%
0.01%
-12.5%
Q1 2021$135,194,000
-7.1%
996,933
-12.4%
0.01%
-11.1%
Q4 2020$145,572,000
+12.8%
1,137,811
-0.8%
0.01%0.0%
Q3 2020$129,089,000
+20.0%
1,147,151
+1.6%
0.01%
+12.5%
Q2 2020$107,560,000
-19.0%
1,129,003
-23.6%
0.01%
-33.3%
Q1 2020$132,731,000
+71.2%
1,476,926
+1.0%
0.01%
+140.0%
Q4 2019$77,516,000
+37.8%
1,462,016
+2.7%
0.01%
+25.0%
Q3 2019$56,245,000
-11.5%
1,423,552
-7.9%
0.00%
-20.0%
Q2 2019$63,519,000
-25.9%
1,546,223
-16.0%
0.01%
-28.6%
Q1 2019$85,713,000
+34.4%
1,840,515
+25.7%
0.01%
+16.7%
Q4 2018$63,765,000
-28.0%
1,464,181
-5.4%
0.01%
-14.3%
Q3 2018$88,579,000
+19.0%
1,547,795
+0.9%
0.01%
+16.7%
Q2 2018$74,416,000
+29.9%
1,533,710
+4.7%
0.01%
+20.0%
Q1 2018$57,283,000
+1.4%
1,464,989
+10.0%
0.01%0.0%
Q4 2017$56,510,000
+36.3%
1,331,509
+19.8%
0.01%
+25.0%
Q3 2017$41,465,000
+20.6%
1,111,051
-1.8%
0.00%
+33.3%
Q2 2017$34,386,000
+25.5%
1,131,824
+9.4%
0.00%
+50.0%
Q1 2017$27,395,000
+13.8%
1,034,625
+9.7%
0.00%0.0%
Q4 2016$24,071,000
-25.0%
943,174
+6.3%
0.00%
-33.3%
Q3 2016$32,098,000
+27.6%
886,955
+19.8%
0.00%0.0%
Q2 2016$25,163,000
+11.8%
740,403
-13.2%
0.00%
+50.0%
Q1 2016$22,514,000
-10.6%
853,062
+65.1%
0.00%
-33.3%
Q4 2015$25,196,000
+202.3%
516,603
+54.3%
0.00%
+200.0%
Q3 2015$8,335,000
-7.1%
334,854
+18.1%
0.00%0.0%
Q2 2015$8,973,000
-4.0%
283,638
+15.6%
0.00%0.0%
Q1 2015$9,343,000
+2.4%
245,460
+4.8%
0.00%0.0%
Q4 2014$9,128,000
+40.3%
234,277
+8.9%
0.00%0.0%
Q3 2014$6,507,000
-65.3%
215,192
-61.0%
0.00%
-50.0%
Q2 2014$18,769,000
+406.6%
552,445
+414.0%
0.00%
Q1 2014$3,705,000
+3.3%
107,479
+18.7%
0.00%
Q4 2013$3,586,00090,5110.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders